Rick O'Connor, Restera (FKA Invicta Medical) - Neurostim System for Sleep Apnea | LSI Europe '24

Restera is a clinical-stage medical technology company developing a first-of-its-kind treatment for sleep apnea. Restera’s intelligent neurostimulation system is designed to address the shortcomings of existing therapies, which are expensive, intrusive and yield low patient compliance rates.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Rick O'Connor
Rick O'Connor
CEO, Invicta Medical/Restera